BlackRock, Inc. Reduces Stake in Fate Therapeutics Inc
BlackRock, Inc. has significantly reduced its stake in Fate Therapeutics Inc by selling 7,874,330 shares at $2.70 per share, leaving them with 2,194,284 shares. This move suggests a strategic reevaluation of its investment in the biopharmaceutical company, which is currently considered significantly overvalued despite …
FATE
main company
Sharemaestro market context
Trend signal active
52 weeks +123.5%